Cargando…

Nrf2 Activators as Attractive Therapeutics for Diabetic Nephropathy

Detalles Bibliográficos
Autor principal: de Haan, Judy B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198074/
https://www.ncbi.nlm.nih.gov/pubmed/22025774
http://dx.doi.org/10.2337/db11-1072
_version_ 1782214377254944768
author de Haan, Judy B.
author_facet de Haan, Judy B.
author_sort de Haan, Judy B.
collection PubMed
description
format Online
Article
Text
id pubmed-3198074
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-31980742012-11-01 Nrf2 Activators as Attractive Therapeutics for Diabetic Nephropathy de Haan, Judy B. Diabetes Commentary American Diabetes Association 2011-11 2011-10-17 /pmc/articles/PMC3198074/ /pubmed/22025774 http://dx.doi.org/10.2337/db11-1072 Text en © 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Commentary
de Haan, Judy B.
Nrf2 Activators as Attractive Therapeutics for Diabetic Nephropathy
title Nrf2 Activators as Attractive Therapeutics for Diabetic Nephropathy
title_full Nrf2 Activators as Attractive Therapeutics for Diabetic Nephropathy
title_fullStr Nrf2 Activators as Attractive Therapeutics for Diabetic Nephropathy
title_full_unstemmed Nrf2 Activators as Attractive Therapeutics for Diabetic Nephropathy
title_short Nrf2 Activators as Attractive Therapeutics for Diabetic Nephropathy
title_sort nrf2 activators as attractive therapeutics for diabetic nephropathy
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198074/
https://www.ncbi.nlm.nih.gov/pubmed/22025774
http://dx.doi.org/10.2337/db11-1072
work_keys_str_mv AT dehaanjudyb nrf2activatorsasattractivetherapeuticsfordiabeticnephropathy